Android Apple

In spite of recent selling, insiders still control 53% of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)

By Yahoo! Finance   |   4 months ago
In spite of recent selling, insiders still control 53% of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) has 5 investors owning a majority stake of 51%. Insiders hold 53% shares, indicating control. Institutional ownership and analyst sentiments impact stock performance.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.